2/20/24 16:06 | 2/16/24 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S.d | -41 | 15.62 | 0 | -3 | -2 | 109 | D | | | | | | | | | | | | | | |
1/18/24 16:15 | 1/16/24 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -35 | 14.47 | 0 | -2 | -3 | 94 | D | | | | | | | | | | | | | | |
12/14/23 16:05 | 12/13/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -43 | 15.37 | 0 | -3 | -3 | 97 | D | | | | | | | | | | | | | | |
10/31/23 16:11 | 10/30/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -28 | 12.02 | 0 | -2 | -3 | 91 | D | | | | | | | | | | | | | | |
10/4/23 16:05 | 10/2/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -37 | 12.68 | 0 | -3 | -3 | 85 | D | | | | | | | | | | | | | | |
6/21/23 16:05 | 6/16/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -24 | 14.40 | 0 | -2 | -2 | 88 | D | | | | | | | | | | | | | | |
2/17/23 16:07 | 2/16/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S.d | -15 | 15.10 | 0 | -1 | -1 | 88 | D | | | | | | | | | | | | | | |
1/19/23 16:05 | 1/17/23 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -51 | 21.24 | 0 | -2 | -3 | 73 | D | | | | | | | | | | | | | | |
10/5/22 16:05 | 10/3/22 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -48 | 18.73 | 0 | -3 | -3 | 74 | D | | | | | | | | | | | | | | |
6/21/22 16:37 | 6/16/22 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -19 | 10.75 | 0 | -2 | -2 | 77 | D | | | | | | | | | | | | | | |
2/18/22 17:01 | 2/16/22 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -9 | 9.05 | 0 | -1 | -1 | 77 | D | | | | | | | | | | | | | | |
10/6/21 16:00 | 10/4/21 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S | -88 | 33.17 | 0 | -3 | -5 | 46 | D | | | | | | | | | | | | | | |
2/18/21 19:00 | 2/16/21 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | S.d | -6 | 48.87 | 0 | 0 | 0 | 48 | D | | | | | | | | | | | | | | |
12/11/20 16:10 | 12/9/20 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | M.d | 7 | 34.43 | 0 | 0 | 1 | 37 | D | | | | | | | | | | | | | | |
11/18/20 19:31 | 11/16/20 | DCPH | Deciphera Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | M.d | 93 | 34.43 | 0 | 3 | 8 | 37 | D | | | | | | | | | | | | | | |
4/5/18 20:07 | 4/3/18 | PULM | Pulmatrix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | D | | P.d | 0 | 0.00 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |
4/4/18 16:39 | 4/3/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -177 | 38.43 | 0 | -5 | -6 | 77 | D | | | | | | | | | | | | | | |
1/4/18 19:02 | 1/3/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -198 | 42.71 | 0 | -5 | -5 | 82 | D | | | | | | | | | | | | | | |
9/14/17 17:02 | 9/12/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -707 | 38.41 | 0 | -18 | -18 | 87 | D | | | | | | | | | | | | | | |
7/7/17 16:55 | 7/5/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 57 | 7.12 | 0 | 8 | 8 | 105 | D | | | | | | | | | | | | | | |
7/7/17 16:55 | 7/5/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -512 | 32.00 | 0 | -16 | -13 | 105 | D | | | | | | | | | | | | | | |
1/6/17 17:12 | 1/4/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -55 | 27.46 | 12 | -2 | -2 | 105 | D | -29 | -27 | -20 | -25 | -27 | -6 | -1 | 6 | 1 | 0 | -8 | -1 | | |
8/11/16 17:28 | 8/10/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 131 | 6.94 | 8 | 19 | 21 | 107 | D | -4 | 1 | 12 | -3 | -18 | -14 | -16 | -13 | 2 | 2 | 7 | -5 | -17 | |
7/7/16 16:06 | 7/7/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 32 | 5.28 | 13 | 6 | 7 | 88 | D | 10 | 16 | -14 | 8 | 0 | -6 | 3 | 1 | 2 | -3 | -2 | 4 | -19 | |
7/6/16 17:47 | 7/1/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 68 | 4.85 | 13 | 14 | 21 | 82 | D | -2 | 8 | -27 | 10 | -4 | -8 | -6 | -6 | -2 | 2 | -1 | 3 | -27 | |
7/6/16 17:47 | 7/1/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -903 | 34.74 | 13 | -26 | -24 | 82 | D | -2 | 8 | -27 | 10 | -4 | -8 | -6 | -6 | -2 | 2 | -1 | 3 | -27 | |
4/8/16 16:02 | 4/6/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.dm | -832 | 32.00 | 11 | -26 | -22 | 94 | D | -14 | -11 | 30 | -15 | 30 | 33 | 22 | 8 | -3 | 1 | -6 | 8 | 16 | -17 |
4/8/16 16:02 | 4/7/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 71 | 5.08 | 11 | 14 | 17 | 94 | D | -14 | -11 | 30 | -15 | 30 | 33 | 22 | 8 | -3 | 1 | -6 | 8 | 16 | -17 |
10/16/15 16:41 | 10/15/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -140 | 23.28 | 8 | -6 | -6 | 100 | M | 10 | -17 | -28 | -26 | -14 | -11 | 0 | 3 | 4 | 4 | 46 | 38 | 29 | 22 |
9/18/15 16:15 | 9/16/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S | -66 | 33.24 | 7 | -2 | -2 | 106 | M | | 37 | -18 | 10 | 26 | 23 | 12 | 2 | -7 | -19 | -33 | 24 | -30 | -4 |
8/25/15 16:17 | 8/24/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 78 | 3.88 | 6 | 20 | 48 | 62 | D | | -1 | -31 | -19 | -14 | -6 | -16 | -12 | 5 | 7 | 14 | 44 | -2 | 14 |
8/19/15 16:38 | 8/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 10 | 1.79 | 5 | 6 | 15 | 42 | M | | 4 | -20 | -7 | 7 | 9 | 9 | -5 | -8 | -13 | 13 | 15 | -15 | -3 |
8/19/15 16:38 | 8/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -218 | 31.13 | 5 | -7 | -14 | 42 | M | | 4 | -20 | -7 | 7 | 9 | 9 | -5 | -8 | -13 | 13 | 15 | -15 | -3 |
7/21/15 16:10 | 7/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 6 | 1.25 | 5 | 5 | 12 | 44 | M | | 22 | -22 | -3 | 0 | 7 | 9 | 1 | 5 | -7 | 0 | -20 | 5 | 5 |
7/21/15 16:10 | 7/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -195 | 32.46 | 5 | -6 | -12 | 44 | M | | 22 | -22 | -3 | 0 | 7 | 9 | 1 | 5 | -7 | 0 | -20 | 5 | 5 |
6/19/15 16:41 | 6/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 10 | 1.79 | 5 | 6 | 14 | 45 | M | | -8 | -16 | -25 | 7 | -6 | 2 | 2 | 3 | 1 | 5 | 12 | 41 | 10 |
6/19/15 16:41 | 6/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -221 | 31.54 | 5 | -7 | -14 | 45 | M | | -8 | -16 | -25 | 7 | -6 | 2 | 2 | 3 | 1 | 5 | 12 | 41 | 10 |
5/19/15 16:26 | 5/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 10 | 1.79 | 7 | 6 | 14 | 46 | M | | 2 | -7 | -15 | -5 | 5 | 11 | 2 | 1 | 2 | -6 | -2 | 8 | -3 |
5/19/15 16:26 | 5/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -227 | 32.37 | 7 | -7 | -13 | 46 | M | | 2 | -7 | -15 | -5 | 5 | 11 | 2 | 1 | 2 | -6 | -2 | 8 | -3 |
4/21/15 16:44 | 4/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 2 | 0.4800 | 8 | 4 | 9 | 48 | M | | -13 | 16 | -19 | -18 | -12 | -1 | -1 | 0 | -6 | -2 | -3 | -28 | -13 |
4/21/15 16:44 | 4/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -168 | 33.52 | 8 | -5 | -10 | 48 | M | | -13 | 16 | -19 | -18 | -12 | -1 | -1 | 0 | -6 | -2 | -3 | -28 | -13 |
4/17/15 16:08 | 4/16/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 47 | 3.88 | 8 | 12 | 60 | 32 | D | | -1 | 17 | -16 | -17 | -6 | 0 | 0 | 0 | 1 | -6 | -4 | -34 | -7 |
3/20/15 17:12 | 3/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 6 | 1.25 | 9 | 5 | 15 | 37 | M | | 7 | 66 | 13 | 13 | 4 | 4 | 3 | -2 | -13 | -19 | -24 | -16 | -39 |
3/20/15 17:12 | 3/18/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -247 | 41.18 | 9 | -6 | -14 | 37 | M | | 7 | 66 | 13 | 13 | 4 | 4 | 3 | -2 | -13 | -19 | -24 | -16 | -39 |
3/6/15 16:06 | 3/4/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | M.d | 10 | 1.79 | 8 | 6 | 17 | 38 | M | | -21 | 61 | 16 | 7 | 9 | 5 | 4 | 1 | 4 | -15 | -21 | -27 | -29 |
3/6/15 16:06 | 3/4/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | EVP,Chie | S.d | -285 | 40.75 | 8 | -7 | -16 | 38 | M | | -21 | 61 | 16 | 7 | 9 | 5 | 4 | 1 | 4 | -15 | -21 | -27 | -29 |
1/22/15 16:17 | 1/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 10 | 1.79 | 11 | 6 | 15 | 43 | M | | -24 | 46 | 34 | -9 | 4 | -5 | -5 | 1 | 2 | 3 | -13 | -17 | -12 |
1/22/15 16:17 | 1/20/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -291 | 41.64 | 11 | -7 | -14 | 43 | M | | -24 | 46 | 34 | -9 | 4 | -5 | -5 | 1 | 2 | 3 | -13 | -17 | -12 |
12/19/14 17:20 | 12/17/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.dm | 10 | 1.61 | 16 | 6 | 17 | 41 | M | | 49 | 16 | 67 | 19 | 4 | -7 | 7 | -1 | 4 | 0 | 5 | -17 | 13 |
12/19/14 17:20 | 12/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -201 | 40.16 | 16 | -5 | -11 | 41 | M | | 49 | 16 | 67 | 19 | 4 | -7 | 7 | -1 | 4 | 0 | 5 | -17 | 13 |
12/12/14 16:37 | 12/10/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 20 | 5.08 | 15 | 4 | 11 | 40 | M | | 48 | 22 | 61 | 8 | 21 | 17 | -3 | -9 | -3 | -3 | -2 | -26 | 1 |
12/12/14 16:37 | 12/10/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -217 | 43.46 | 15 | -5 | -11 | 40 | M | | 48 | 22 | 61 | 8 | 21 | 17 | -3 | -9 | -3 | -3 | -2 | -26 | 1 |
12/12/14 16:37 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.a | -63 | 31.51 | 15 | -2 | -13 | 14 | D | | 48 | 22 | 61 | 8 | 21 | 17 | -3 | -9 | -3 | -3 | -2 | -26 | 1 |
11/18/14 17:20 | 11/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 2 | 0.4800 | 8 | 4 | 11 | 42 | M | | 68 | 5 | 16 | 13 | -7 | -3 | -2 | -3 | 9 | 19 | 22 | -1 | 7 |
11/18/14 17:20 | 11/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -172 | 33.76 | 8 | -5 | -11 | 42 | M | | 68 | 5 | 16 | 13 | -7 | -3 | -2 | -3 | 9 | 19 | 22 | -1 | 7 |
11/14/14 16:03 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 12 | 3.06 | 8 | 4 | 10 | 43 | M | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
11/14/14 16:03 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -163 | 33.11 | 8 | -5 | -10 | 43 | M | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
10/20/14 16:22 | 10/20/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -143 | 29.10 | 8 | -5 | -10 | 44 | M | | 31 | -20 | 7 | 16 | -3 | -4 | 0 | 0 | 18 | 14 | 43 | 16 | -13 |
10/9/14 16:59 | 10/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 7 | 1.80 | 6 | 4 | 9 | 49 | M | | 30 | -20 | 0 | 7 | 23 | 2 | -3 | 2 | 0 | 17 | 40 | 17 | -16 |
10/9/14 16:59 | 10/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -150 | 29.50 | 6 | -5 | -9 | 49 | M | | 30 | -20 | 0 | 7 | 23 | 2 | -3 | 2 | 0 | 17 | 40 | 17 | -16 |
9/19/14 16:18 | 9/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -127 | 25.48 | 4 | -5 | -9 | 50 | M | | | -37 | -28 | -14 | -10 | 0 | -4 | 3 | 18 | 19 | 63 | 71 | 47 |
9/4/14 16:12 | 9/3/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 7 | 1.80 | 4 | 4 | 8 | 55 | M | | | -51 | -14 | -8 | -12 | -7 | -6 | -3 | -1 | 17 | 37 | 60 | 13 |
9/4/14 16:12 | 9/3/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -129 | 25.82 | 4 | -5 | -8 | 55 | M | | | -51 | -14 | -8 | -12 | -7 | -6 | -3 | -1 | 17 | 37 | 60 | 13 |
8/19/14 16:24 | 8/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -74 | 29.62 | 5 | -3 | -4 | 56 | M | | | -35 | -6 | 2 | 2 | 2 | 0 | -3 | 0 | -10 | 17 | 34 | 7 |
8/15/14 16:05 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 9 | 1.43 | 5 | 6 | 11 | 59 | M | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
8/15/14 16:05 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -223 | 29.79 | 5 | -8 | -11 | 59 | M | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
8/13/14 16:25 | 8/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 14 | 1.80 | 5 | 8 | 37 | 30 | D | | | -36 | -13 | -17 | 2 | -3 | -2 | 2 | -3 | -12 | 10 | 35 | -2 |
7/25/14 16:12 | 7/23/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 18 | 1.80 | 8 | 10 | 84 | 22 | D | | | -45 | -12 | -19 | -16 | 2 | 3 | 2 | 5 | -2 | 3 | 40 | 6 |
7/22/14 16:34 | 7/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -66 | 26.22 | 8 | -3 | -6 | 42 | M | | | -45 | -26 | -16 | -20 | -11 | -3 | 4 | 7 | 7 | 8 | 55 | 15 |
7/11/14 17:32 | 7/9/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 3 | 0.4800 | 11 | 6 | 15 | 45 | M | | | -26 | -20 | 1 | -11 | -11 | -3 | -6 | -16 | -1 | 0 | 36 | -1 |
7/11/14 17:32 | 7/9/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -217 | 28.99 | 11 | -8 | -14 | 45 | M | | | -26 | -20 | 1 | -11 | -11 | -3 | -6 | -16 | -1 | 0 | 36 | -1 |
6/20/14 16:59 | 6/18/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -86 | 34.42 | 11 | -3 | -5 | 46 | M | | | 24 | -12 | 7 | 16 | 2 | 4 | 0 | 0 | -22 | -29 | 14 | -11 |
6/13/14 16:53 | 6/11/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 3 | 0.4800 | 11 | 6 | 14 | 49 | M | | | 14 | -25 | 0 | 10 | 14 | 6 | -3 | 1 | -16 | -23 | 28 | -7 |
6/13/14 16:53 | 6/11/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -249 | 33.23 | 11 | -8 | -13 | 49 | M | | | 14 | -25 | 0 | 10 | 14 | 6 | -3 | 1 | -16 | -23 | 28 | -7 |
5/30/14 16:35 | 5/28/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S.d | -232 | 30.97 | 10 | -8 | -13 | 50 | M | | | 42 | -36 | -20 | -6 | -4 | -1 | 1 | 2 | 16 | -5 | 21 | 13 |
5/30/14 16:35 | 5/28/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | M.d | 3 | 0.4800 | 10 | 6 | 14 | 50 | M | | | 42 | -36 | -20 | -6 | -4 | -1 | 1 | 2 | 16 | -5 | 21 | 13 |
5/21/14 18:52 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -79 | 31.54 | 12 | -3 | -5 | 52 | M | | | 61 | -28 | -12 | -8 | 0 | 1 | 6 | 5 | 15 | -3 | 12 | 12 |
4/24/14 17:07 | 4/22/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sherman Matthew L | MA | O | SVP,Chie | S | -179 | 35.83 | 12 | -5 | -9 | 52 | M | | | 49 | -41 | -31 | -13 | -9 | -13 | 2 | 7 | -2 | -12 | -8 | 7 |